6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
6m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
6m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
6m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion
6m ago	Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway
7m ago	Intuitive Announces Innovations to Advance Quintuple Aim

About

2.97USD+0.05 +1.71%

Closed • Updated at 13:22 GMT+00:00

Market Cap$324.30M

Volume2.62M

Beta0.97

RSI31.78

Health TechnologyBiotechnology

Rocket Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher

Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Community Chat

Ask AI